An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs
NCT ID: NCT03740230
Last Updated: 2024-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3134 participants
OBSERVATIONAL
2018-09-26
2023-07-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 Infection
NCT03219216
A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection
NCT02966795
Efficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1
NCT03212521
Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6
NCT03341871
Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-Infection
NCT03235349
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The sample size for this study is due to a requirement by local authorities.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hepatitis C
Participants with Hepatitis C Genotypes 1 to 6 receiving Maviret (glecaprevir/pibrentasvir) for 8, 12, or 16 weeks.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants prescribed Maviret in accordance with approved local label.
Exclusion Criteria
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AbbVie
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ABBVIE INC.
Role: STUDY_DIRECTOR
AbbVie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SoonChunHyang University CheonAn Hospital /ID# 209996
Cheonan-si, Chungcheongnam-do, South Korea
Hallym University Sacred Heart Hospital /ID# 210809
Anyang, Gyeonggido, South Korea
The Catholic University of Korea, Bucheon St.Mary's Hospital /ID# 216869
Bucheon-si, Gyeonggido, South Korea
Dongguk University Ilsan Hospital /ID# 210609
Goyang, Gyeonggido, South Korea
National health insurance Service ilsanhospital /ID# 209997
Goyang, Gyeonggido, South Korea
SoonChunHyang University Buchon Hospital /ID# 210618
Habun, Gyeonggido, South Korea
Seoul National University Bundang Hospital /ID# 210616
Seongnam, Gyeonggido, South Korea
The Catholic University of Korea, ST. Vincent's Hospital /ID# 216951
Suwon, Gyeonggido, South Korea
Ajou University Hospital /ID# 209995
Suwon, Gyeonggido, South Korea
The Catholic University of Korea, Uijeongbu ST. Mary's Hospital /ID# 216949
Uijeongbu-si, Gyeonggido, South Korea
Pusan National University Yangsan Hospital /ID# 214960
Yangsan, Gyeongsangnam-do, South Korea
Wonkwang University Hospital /Id# 210620
Iksan, Jeonrabugdo, South Korea
Kwangju Christian Hospital /ID# 210623
Gwangju, Jeonranamdo, South Korea
Yonsei University Health System Severance Hospital /ID# 209636
Seoul, Seoul Teugbyeolsi, South Korea
SMG-SNU Boramae Medical Center /ID# 210610
Seoul, Seoul Teugbyeolsi, South Korea
Dongnam Institute of Radiological & Medical Sciences /ID# 209991
Busan, , South Korea
Good Samsun Hospital /ID# 209291
Busan, , South Korea
Inje University Busan Paik Hospital /ID# 209992
Busan, , South Korea
Inje University Haeundae Hospital /ID# 209993
Busan, , South Korea
Maryknoll Medical Center /ID# 210957
Busan, , South Korea
Dong-A University Hospital /ID# 209450
Busan, , South Korea
Pusan National University Hospital /ID# 209813
Busan, , South Korea
Kosin University Gospel Hospital /ID# 210608
Busan, , South Korea
Samsung Changwon Hospital /ID# 211507
Changwon, , South Korea
Samsung Changwon Hospital /ID# 211743
Changwon, , South Korea
Dankook University Hospital /ID# 209297
Cheonan, , South Korea
Chuncheon Sacred Heart Hospital /ID# 210612
Chuncheon, , South Korea
Kyungpook National University Chilgok Hospital /ID# 209988
Daegu, , South Korea
Keimyung University Dongsan Medical Center /ID# 212144
Daegu, , South Korea
Keimyung University Dongsan Medical Center /ID# 212514
Daegu, , South Korea
Kyungpook National University Hospital /ID# 209294
Daegu, , South Korea
Yeungnam University Medical Center /ID# 209293
Daegu, , South Korea
Kim Jun Hwan Sok Internal Medi /ID# 209292
Daegu, , South Korea
The Catholic University of Korea, Daejeon St.Mary's Hospital /ID# 216952
Daejeon, , South Korea
Chungnam National University Hospital /ID# 209637
Daejeon, , South Korea
Myongji Hospital /ID# 215595
Goyang, , South Korea
CHA Gumi Medical Center, CHA University /ID# 209994
Gumi, , South Korea
Chosun University Hospital /ID# 210607
Gwangju, , South Korea
The Catholic University of Korea Incheon St.Mary's Hospital /ID# 216950
Incheon, , South Korea
Gachon University Gil Medical Center /ID# 212513
Incheon, , South Korea
Inha University Hospital /ID# 210617
Incheon, , South Korea
Jeju National University Hospital /ID# 214700
Jeju City, , South Korea
Chonnam National University Hwasun Hospital /ID# 209990
Jeonnam, , South Korea
Inje University Sanggye Paik Hospital /ID# 210811
Seoul, , South Korea
Korea University Anam Hospital /ID# 210958
Seoul, , South Korea
Seoul National University Hospital /ID# 210959
Seoul, , South Korea
Seoul National University Hospital /ID# 211365
Seoul, , South Korea
Seoul National University Hospital /ID# 211369
Seoul, , South Korea
National Medical Center /ID# 209911
Seoul, , South Korea
Kangdong Sacred Heart Hospital /ID# 210621
Seoul, , South Korea
Asan Medical Center /ID# 210622
Seoul, , South Korea
Gangnam Severance Hospital /ID# 212512
Seoul, , South Korea
Samsung Medical Center /ID# 209296
Seoul, , South Korea
Samsung Medical Center /ID# 209635
Seoul, , South Korea
Chung-Ang University Hostipal /ID# 209295
Seoul, , South Korea
Ewha Womans University Mokdong Hospital /ID# 214961
Seoul, , South Korea
Ewha Womans University Mokdong Hospital /ID# 216412
Seoul, , South Korea
Korea University Guro Hospital /ID# 209989
Seoul, , South Korea
St. Carollo General Hospital /ID# 210619
Suncheon, , South Korea
Ulsan University Hospital /ID# 210810
Ulsan, , South Korea
Wonju Severance Christian Hospital /ID# 210611
Wŏnju, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
clinical study report synopsis
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P19-423
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.